EUROLAB
usp-1058-analytical-instrument-qualification-for-impurity-studies
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

USP <1058>: Analytical Instrument Qualification for Impurity Studies - Eurolabs Testing Service

USP <1058> is a comprehensive standard that governs the analytical instrument qualification for impurity studies in pharmaceutical manufacturing. This standard is essential for ensuring the accuracy, precision, and reliability of laboratory results, which is critical to product safety and regulatory compliance.

Legal and Regulatory Framework

The legal and regulatory framework surrounding USP <1058> testing is governed by various national and international standards, including:

  • ISO 15189:2012 (Medical laboratories - Requirements for quality and competence)

  • ASTM E2500-17 (Standard Guide for Establishing Consistent and Reproducible Analytical Measurement Data)

  • EN ISO/IEC 17025:2017 (General requirements for the competence of testing and calibration laboratories)

  • TSE (Turkish Standards Institution) GOST R ISO/IEC 17025-2009

  • Other relevant national standards, such as FDA guidelines for laboratory validation

    • International and National Standards

    The following international and national standards are applicable to USP <1058> testing:

  • ISO 15189:2012 (Medical laboratories - Requirements for quality and competence)

  • EN ISO/IEC 17025:2017 (General requirements for the competence of testing and calibration laboratories)

  • TSE GOST R ISO/IEC 17025-2009

  • FDA guidelines for laboratory validation

    • Standard Development Organizations

    Standard development organizations, such as the International Organization for Standardization (ISO), play a crucial role in developing and updating standards. These organizations ensure that standards are based on scientific evidence and best practices.

    Evolution of Standards

    Standards evolve over time to reflect changes in technology, science, and regulatory requirements. Regular updates ensure that laboratories remain compliant with the latest regulations and best practices.

    Specific Standard Numbers and Scope

    The following standard numbers and scope are relevant to USP <1058> testing:

  • ISO 15189:2012 (Medical laboratories - Requirements for quality and competence)

    • Scope: Ensures the quality and competence of medical laboratories

  • EN ISO/IEC 17025:2017 (General requirements for the competence of testing and calibration laboratories)

    • Scope: Establishes general requirements for the competence of testing and calibration laboratories

    Standard Compliance Requirements

    Standard compliance requirements vary depending on the industry, sector, or region. Laboratories must ensure that they comply with relevant standards and regulations to maintain accreditation and certification.

    Standard-Related Information Conclusion

    Understanding the standard-related information is essential for ensuring the accuracy, precision, and reliability of laboratory results. Eurolabs testing service complies with all relevant national and international standards, guaranteeing high-quality results that meet regulatory requirements.

    Why USP <1058> Testing Is Required

    USP <1058> testing is required to ensure the accuracy, precision, and reliability of laboratory results. Impurity studies are critical in pharmaceutical manufacturing, as they help identify potential contaminants that can affect product safety and efficacy.

    Business and Technical Reasons for Conducting USP <1058> Testing

    Conducting USP <1058> testing provides several business and technical advantages:

  • Ensures compliance with regulatory requirements

  • Demonstrates quality and competence in laboratory practices

  • Enhances customer confidence and trust

  • Supports innovation and research development

    • Consequences of Not Performing This Test

    Failing to conduct USP <1058> testing can have severe consequences, including:

  • Non-compliance with regulatory requirements

  • Product contamination and safety risks

  • Reputation damage and loss of customer trust

    • Industries and Sectors That Require This Testing

    The following industries and sectors require USP <1058> testing:

  • Pharmaceutical manufacturing

  • Biotechnology

  • Medical device manufacturing

  • Food and beverage industry

    • Risk Factors and Safety Implications

    USP <1058> testing helps mitigate risk factors and safety implications associated with impurity studies, including:

  • Contamination risks

  • Product safety and efficacy concerns

  • Regulatory non-compliance risks

    • Quality Assurance and Quality Control Aspects

    USP <1058> testing ensures quality assurance and quality control aspects, including:

  • Sample preparation and analysis

  • Instrument calibration and validation

  • Data collection and recording

  • Reporting and documentation

    • Contribution to Product Safety and Reliability

    USP <1058> testing contributes significantly to product safety and reliability by ensuring that laboratory results are accurate, precise, and reliable.

    Competitive Advantages of Having This Testing Performed

    Performing USP <1058> testing provides several competitive advantages, including:

  • Enhanced customer confidence and trust

  • Demonstrated quality and competence in laboratory practices

  • Regulatory compliance and non-compliance risk mitigation

    • Standard Requirements and Needs Conclusion

    Understanding the standard requirements and needs is essential for ensuring the accuracy, precision, and reliability of laboratory results. Eurolabs testing service ensures compliance with all relevant national and international standards, guaranteeing high-quality results that meet regulatory requirements.

    Eurolabs Testing Service

    Eurolab offers a comprehensive testing service for USP <1058> testing, including:

  • Sample preparation and analysis

  • Instrument calibration and validation

  • Data collection and recording

  • Reporting and documentation

    • Benefits of Eurolabs Testing Service

    Eurolabs testing service provides several benefits, including:

  • Enhanced customer confidence and trust

  • Demonstrated quality and competence in laboratory practices

  • Regulatory compliance and non-compliance risk mitigation

    • How to Get Started with Eurolabs Testing Service

    To get started with Eurolabs testing service, please contact our team for a consultation. We will work closely with you to understand your needs and ensure that our testing service meets your requirements.

    This is just the beginning of the comprehensive guide to Eurolabs USP <1058> testing service. Please let me know if you would like me to continue with the next section.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers